Drug Shortage Report for TARO-TESTOSTERONE GEL
Report ID | 98290 |
Drug Identification Number | 02463792 |
Brand name | TARO-TESTOSTERONE GEL |
Common or Proper name | TARO-TESTOSTERONE GEL |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE |
Strength(s) | 1% |
Dosage form(s) | GEL |
Route of administration | TRANSDERMAL |
Packaging size | 2.5g x30 |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-06 |
Estimated end date | 2019-11-29 |
Actual end date | 2019-11-25 |
Shortage status | Resolved |
Updated date | 2019-12-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-08 | English | Compare |
v2 | 2019-11-08 | French | Compare |
v3 | 2019-11-26 | English | Compare |
v4 | 2019-11-26 | French | Compare |
v5 | 2019-12-13 | English | Compare |
v6 | 2019-12-13 | French | Compare |
Showing 1 to 6 of 6